Ulrike Schwarz-Boeger

Title: Ulrike Schwarz-Boeger: Innovator in Cancer Recurrence Risk Assessment

Introduction

Ulrike Schwarz-Boeger is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of cancer research, particularly in assessing the risk of cancer recurrence. Her innovative approach combines biological markers with computational analysis to provide valuable insights for patient care.

Latest Patents

Ulrike holds a patent for a "Method of judging risk of cancer recurrence and computer program." This patent outlines a method that evaluates the risk of cancer recurrence based on the activity value and expression levels of specific cyclin-dependent kinases (CDKs), as well as the expression levels of uPA and PAI-1. This groundbreaking work has the potential to enhance the accuracy of cancer prognosis and treatment strategies.

Career Highlights

Ulrike is currently associated with Sysmex Corporation, where she continues to advance her research in cancer diagnostics. Her work is characterized by a strong commitment to improving patient outcomes through innovative technological solutions.

Collaborations

Ulrike collaborates with esteemed colleagues, including Hideki Ishihara and Tomoko Matsushima, who contribute to her research endeavors. Their combined expertise fosters a collaborative environment that drives innovation in cancer research.

Conclusion

Ulrike Schwarz-Boeger is a trailblazer in the field of cancer recurrence risk assessment, with her patent and collaborative efforts paving the way for advancements in cancer diagnostics. Her work exemplifies the impact of innovation in healthcare.